Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Occam Sciences

Occam Sciences
2011 FOUNDED
PRIVATE STATUS
Seed LATEST DEAL TYPE
$300K LATEST DEAL AMOUNT
2 INVESTORS
Description

Provider of therapeutic drug development services intended to provide bio-available forms of approved drugs. The company's services includes developing of drugs using green chemistry to design drugs that are more bioavailable, enabling researchers to develop oral drugs.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 33 Whitney Street
  • New Haven, CT 06510
  • United States

+1 (203) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Occam Sciences’s full profile, request a free trial.

Occam Sciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 21-Oct-2011 $300K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Occam Sciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Elm Street Ventures Venture Capital Minority 000 0000 000000 0
Warner Babcock Institute for Green Chemistry Other Minority 000 0000 000000 0

Occam Sciences Executive Team (1)

Name Title Board
Seat
Contact
Info
Robert Bettigole Chief Executive Officer, President, Treasurer & Chairman

Occam Sciences Board Members (5)

Name Representing Role Since Contact
Info
Brian Dixon Occam Sciences Board Member 000 0000
David Whittaker MD Elm Street Ventures Board Member 000 0000
John Warner Occam Sciences Board Member 000 0000
Joseph Pont Occam Sciences Board Member 000 0000
Robert Bettigole Self Chief Executive Officer, President, Treasurer & Chairman 000 0000